William R Heath Selected Research

William R Heath Research Topics

Disease

30	Infections 11/2022 - 01/2002
16	Malaria 05/2022 - 02/2006
8	Virus Diseases (Viral Diseases) 01/2021 - 03/2002
8	Neoplasms (Cancer) 01/2021 - 05/2003
5	Inflammation (Inflammations) 10/2020 - 01/2002
2	Cerebral Malaria 06/2011 - 04/2009
2	Autoimmune Diseases (Autoimmune Disease) 05/2004 - 01/2002
1	Hypoxia (Hypoxemia) 01/2021
1	Parasitic Diseases (Parasitic Disease) 01/2021
1	Lymphopenia (Lymphocytopenia) 12/2020
1	Chronic Disease (Chronic Diseases) 10/2020
1	Communicable Diseases (Infectious Diseases) 01/2013
1	Leigh Disease (Leigh's Disease) 06/2012
1	Neurodegenerative Diseases (Neurodegenerative Disease) 06/2012
1	Experimental Arthritis 06/2009
1	Human Influenza (Influenza) 02/2009
1	Herpes Simplex 02/2009
1	Carcinogenesis 06/2004
1	Skin Diseases (Skin Disease) 07/2003
1	Cytokine Release Syndrome 02/2003

Drug/Important Bio-Agent (IBA)

22	AntigensIBA 01/2021 - 01/2002
9	VaccinesIBA 01/2021 - 11/2007
6	Peptides (Polypeptides)IBA 05/2022 - 01/2002
4	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021 - 05/2004
3	EpitopesIBA 01/2021 - 02/2003
3	CD40 Ligand (CD40L)IBA 12/2017 - 01/2002
3	DNA (Deoxyribonucleic Acid)IBA 06/2012 - 06/2004
2	Proteins (Proteins, Gene)FDA Link 10/2020 - 06/2012
2	Viral AntigensIBA 01/2018 - 02/2003
2	OvalbuminIBA 02/2009 - 12/2007
2	LigandsIBA 02/2006 - 02/2003
2	Simplexvirus glycoprotein BIBA 05/2003 - 01/2002
1	Broadly Neutralizing AntibodiesIBA 11/2022
1	Conjugate VaccinesIBA 05/2022
1	CytokinesIBA 01/2021
1	hemozoinIBA 01/2021
1	Interleukin-10 (Interleukin 10)IBA 01/2021
1	HLA-DR Antigens (HLA-DR)IBA 01/2021
1	Adrenergic Agonists (Adrenergic Receptor Agonist)IBA 01/2021
1	Biological ProductsIBA 01/2021
1	Interferon Type IIBA 12/2020
1	Dinoprostone (PGE2)FDA Link 10/2020
1	chenodeoxycholate sulfate conjugate (CDCS)IBA 10/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2020
1	Ribosomal Proteins (Ribosomal Protein)IBA 10/2020
1	ribosomal protein L6IBA 10/2020
1	RezafunginIBA 01/2020
1	GlycolipidsIBA 01/2020
1	Synthetic Vaccines (Recombinant Vaccines)IBA 01/2020
1	Interferon Regulatory Factor-3 (Interferon Regulatory Factor 3)IBA 01/2018
1	RNA (Ribonucleic Acid)IBA 03/2017
1	Interleukin-15 (Interleukin 15)IBA 01/2016
1	AntibodiesIBA 03/2015
1	Electron Transport Complex I (NADH-CoQ Reductase)IBA 06/2012
1	IntegrinsIBA 05/2012
1	Granzymes (Granzyme)IBA 06/2011
1	Collagen Type II (Type II Collagen)IBA 06/2009
1	AutoantibodiesIBA 06/2009
1	ChemokinesIBA 04/2009
1	Chemokine ReceptorsIBA 04/2009
1	Interleukin-18 (Interleukin 18)IBA 12/2007
1	Interleukin-12 Subunit p40IBA 12/2007
1	Interferon-gamma (Interferon, gamma)IBA 12/2007
1	Interleukin-12 (IL 12)IBA 12/2007
1	Toll-Like Receptors (Toll-Like Receptor)IBA 02/2006
1	Antiviral Agents (Antivirals)IBA 02/2006
1	Glycoproteins (Glycoprotein)IBA 01/2004
1	Hemagglutinins (Hemagglutinin)IBA 05/2003
1	Gemcitabine FDA Link 05/2003
1	Indicators and Reagents (Reagents)IBA 05/2003
1	Neoplasm Antigens (Tumor Antigens)IBA 05/2003
1	Immunodominant EpitopesIBA 05/2003
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 02/2003
1	Brefeldin AIBA 02/2003
1	5-(6)-carboxyfluorescein diacetate succinimidyl ester (CFSE)IBA 01/2002

Therapy/Procedure

3	Immunotherapy 03/2015 - 05/2003
1	Therapeutics 10/2020
1	Ligation 05/2004